UCSF Type 1 Diabetes Clinical Trials

Home
United States
San Francisco, CA
UCSF Type 1 Diabetes Clinical Trials

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from UCSF Type 1 Diabetes Clinical Trials, Medical Research Center, Mission Hall UCSF: 550 16th Street, San Francisco, CA.

UCSF is a world leader in type 1 diabetes research & clinical trials (including studies for those newly diagnosed), helping to increase the field's understanding of fundamental mechanisms underlying the disease & pioneering therapies to treat it.

04/21/2023

Have you signed up for the upcoming 2023 Diabetes + Mental Health Conference? You can expect an amazing line-up of sessions and speakers. The keynote speakers are , Adam Brown and . The conference will also have sessions on topics ranging from relationships to boundaries to ADHD or trauma. Two tracks, one focused on patients and one focused on providers, are available with all sessions recorded, so you can actually watch all of them during the 30 day replay window! Early bird registration ends Monday!

Susan Guzman of the Behavioral Diabetes Institute, Jane K. Dickinson, , and will also speak!

You can find the registration link in our story and in ’s bio!

04/01/2023

Join us tomorrow (Sun.) in Simi Valley at Rancho Simi Community Park for a Community One Walk!
TrialNet will present at the community walk to answer questions about Risk Screening & other trials. 🙂

Hosted by community member Ryan Dalzell, this will be a fun day of gathering as a T1D community in Ventura County and walking for a world without type 1 diabetes.

02/23/2023

TOPPLE is currently still enrolling!

Adults, 18-45 in the U.S, who’ve been diagnosed with type 1 diabetes in the past 4 years may be eligible for an exciting TrialNet study!

The TOPPLE Study is testing the safety of a new treatment called plasmid therapy in adults with type 1 diabetes. A plasmid is a relatively new way to carry treatment directly into cells where it can communicate with the immune system.
Learn more about this exciting study with the link in our bio! Message us if you have any questions.

02/16/2023

Join us next Tuesday, @ 7pm, as Dr. Gitelman joins UCLA’s Diabetes Link to discuss TrialNet Risk Screening & the latest T1D research advancements. He we will also be discussing Teplizumab, the latest groundbreaking therapy approved by the FDA in November! 🧬💙

Zoom Link will be shared in a few days. Stay tuned!

02/01/2023

💡🔬So now that you know this fact, how can you help your family, the T1D community, & T1D research??
➡️ Swipe to learn more!

Pathway to Prevention screening is the first step for all TrialNet prevention studies. Screening is offered at no cost to eligible individuals to evaluate their personal risk of developing the disease. This unique screening can identify the early stages of type 1 diabetes (T1D) years before any symptoms appear.

Learn more about TrialNet’s Pathway to Prevention here: https://trialnet.org/our-research/risk-screening

12/22/2022

🦸🏻‍♀️🦸🏻‍♀️⚡️ We are continuing TrialNet’s T1D Hero spotlight with 2 very special heroes: sisters Citaly & Maria! Super siblings united!⚡️✨

Both Citaly & Maria learned that they were at increased risk for type 1 diabetes (T1D) after their older brother’s diagnosis. Each strong, young woman then joined a separate TrialNet prevention study.
Citaly was diagnosed with T1D during her participation in the Exploring Immune Effects of Oral Insulin Study, under what her mother says were “the best possible circumstances.” Maria, who participated in the Abatacept Prevention Study, remains T1D-free! 🤯💙

Swipe to read more or click on the link in our bio to read their full story!

Illustrated by

11/19/2022

🚨Yesterday, on November 17, the FDA approved the immunotherapy drug, teplizumab, for the delay of T1D in at-risk individuals. TrialNet was instrumental in the FDA’s approval of teplizumab as the first drug to delay T1D in people at risk. We want to take a moment to thank the other TrialNet research teams across the country. Without collective work, advancements in T1D research would not be possible! 🧬💙We are one step closer to a future without T1D!💙

11/16/2022

🦸🏻‍♀️🦸🏼🦸🏽‍♂️🦸🏾‍♀️🦸🏻🦸🏼‍♂️⚡️ Introducing the next hero in our T1D Heroes Academy!
💙⚡️ Meet hero Lilah! 💙⚡️❄️
Foggy vapors rise from Lilah’s icy,curly tendrils & little puffs of smoke gather about her fingertips as she twirls in relevé. Lilah glides across the room smooth as ice during dance class & finds it easy to keep her nerves cool before recitals.

Lilah became a TrialNet hero at just 4 years old after getting screened for T1D & enrolling in the Hydroxychloroquine (HCQ) Prevention Study! Swipe to read more or click on the link in our bio to read her full story! ❄️⚡️✨

Illustrated by

11/11/2022

Check out Hero Tim’s spectacular story! ⚡️
He has been our long-term research participant at UCSF! 😍💙

As Hero Tim says:
“Seek out education and support. Don’t go through it alone, and don’t let anything stop you. As we share our stories, we can show others it’s okay. You can do this!” 🦸🏻‍♂️⚡️

11/08/2022

TrialNet-UCSF will be at San Diego’s One Walk this Saturday (11/12)! 💙
Come ask us about risk screening & research. We hope to see you there!
For more info or to register & join us for the November 12th One Walk at Balboa Park, please visit: walk.jdrf.org/sandiego

11/08/2022

🦸🏻‍♂️⚡️ Today’s T1D Hero spotlight is very special: Meet Tim, our very own research participant at UCSF!!! 💙💙
This hero has been in our TN-18 Abatacept Prevention Study for 9 years! 🤯

If you ask Tim what he thinks makes someone a superhero, he’ll tell you anyone can be one. “Each one of us has the ability to switch from a Clark Kent into a Superman and make life better for the next person. Are you ready to step out of the phone booth and make life better for someone else?” ⚡️⚡️⚡️

Read more about Tim with the link in our bio!

Illustrated by

11/03/2022

November is Diabetes Awareness Month! 💙 Research shows that relatives [of people with T1D] have a 15x higher risk of developing Type 1.

We urge family members to learn about their risk of developing T1D. Anyone who screens through our free health screening program, Pathway to Prevention, automatically joins TrialNet’s T1D Heroes Academy, where thousands of heroes help advance scientific research on Type 1. Visit the link in our bio to learn more today. 💻📱
————————————
Today, we are explaining how T1D develops in stages. Almost all individuals who develop two or more of these diabetes-related autoantibodies (stage 1 & 2) will eventually be diagnosed with T1D (stage 3). But TrialNet is working to change that! Stay tuned for our latest research updates.💙

10/31/2022

🦸🏻‍♀️🦸🏼🦸🏽‍♂️🦸🏾‍♀️🦸🏻🦸🏼‍♂️⚡️Introducing the next heroes in our T1D Heroes Academy!
💙⚡️ Meet heroes Talia & Ali! 💙⚡️

To get screened like Ali, click the link in our bio to request a screening appointment or an at-home kit today. ⚡️🩸

Illustrated by

10/31/2022

🦸🏻‍♀️🦸🏼🦸🏽‍♂️🦸🏾‍♀️🦸🏻🦸🏼‍♂️⚡️ Introducing the next heroes in our T1D Heroes Academy: Talia & Ali

💙⚡️Sisters Talia and Ali use their superhero powers to prevent health conditions from ending up as emergencies. Talia combines her health informatics skills with time travel to identify who’s headed for trouble. Ali jets through the clouds at superspeed to deliver the news.

Talia’s passion for health prevention screening is personal. After ending up in the hospital with a shocking type 1 diabetes (T1D) diagnosis, she wants to prevent others from the same fate. Talia shares information about TrialNet screening on her T1D Instagram platform and encouraged Ali to get screened. Ali didn’t hesitate; she signed up that very day!
Visit the link in our bio to request a screening appointment or an at-home kit today. ⚡️🩸

Illustrated by

10/27/2022

Introducing TrialNet's T1D Heroes Academy —a global alliance of T1D superheroes beckoned to the front lines of scientific research to benefit all humanity. 🦸🏻‍♀️🦸🏼🦸🏽‍♂️🦸🏾‍♀️🦸🏻🦸🏼‍♂️⚡️
These mighty and courageous heroes rise against adversity to benefit the greater good by participating in TrialNet's free risk screening program and clinical trials. Our heroes want to help us raise awareness and they have agreed to unveil their hero personas to the world in the hope that others will join TrialNet’s T1D Heroes Academy.

With Diabetes Awareness Month beginning in November, we will tell stories about our heroes to raise awareness about T1D research and TrialNet’s free T1D risk screening for relatives. ⚡️💙
Visit the link in our bio to request a screening appointment or an at-home kit today.

Meet our first Hero: LUKE 💙⚡️💙⚡️

Illustrated by

09/27/2022

The JDRF One Walk LA is this weekend, 10/2, at the Rose Bowl!💙
If you haven’t already, go register and tell everyone about the miles you are walking to support our mission to improve the lives of those with Type 1 Diabetes and, hopefully, find a cure.
Come meet other families living with T1D! We will see you this Sunday, October 2, at the Rose Bowl in Pasadena. Check-in starts at 8am. You won’t want to miss the opening ceremonies, beginning at 9:45am!⭐️

We will be there to answer your TrialNet Screening questions, and will also have a phlebotomist on site (if you wish to screen Sunday). 🩸

Registration link is in our story!

09/10/2022

If you’re in the San Diego area, join us today at 4:30pm! Come ask questions about risk-screening & our latest clinical trials 💙
Amazing guest speakers will also be there to answer questions about: T1D technology, carb counting, & more!
💙💉🧬

08/02/2022

Come meet other families living with T1D! 💙

UCLA-TrialNet will be there to provide free Risk Screening. 🩸🧬

Address

Mission Hall UCSF: 550 16th Street
San Francisco, CA
94158

Website

https://diabetes.ucsf.edu/clinical-trials-type-1

Alerts

Be the first to know and let us send you an email when UCSF Type 1 Diabetes Clinical Trials posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to UCSF Type 1 Diabetes Clinical Trials:

Shortcuts

Want your practice to be the top-listed Clinic in San Francisco?

UCSF Type 1 Diabetes Clinical Trials

04/21/2023

04/01/2023

02/23/2023

02/16/2023

02/01/2023

12/22/2022

11/19/2022

11/16/2022

11/11/2022

11/08/2022

11/08/2022

11/03/2022

10/31/2022

10/31/2022

10/27/2022

09/27/2022

09/10/2022

08/02/2022

Address

Website

Alerts

Contact The Practice

Shortcuts

Share

Category